MB-105 in Patients With CD5 Positive T-cell Lymphoma

Clinical trial NCT06534060 · RECRUITING

Trial details

NCT number: NCT06534060
Sponsor: March Biosciences Inc
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, T-Cell

Start date: 2025-02-15
Primary completion: 2028-02-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.